Immunology of Inflammatory Bowel Disease and Molecular Targets for Biologics

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Inflammatory bowel disease (IBD) is an immune-mediated disease and involves a complex interplay of host genetics and environmental influences. Recent advances in the field, including data from genome-wide association studies and microbiome analysis, have started to unravel the complex interaction between host genetics and environmental influences in the pathogenesis of IBD. A drawback of current clinical trials is inadequate or lack of immune phenotyping of patients. However, recent advances in high-throughput technologies provide an opportunity to monitor the dynamic and complex immune system, which may to lead to a more personalized treatment approach in IBD.

Original languageEnglish (US)
Pages (from-to)405-424
Number of pages20
JournalGastroenterology Clinics of North America
Volume43
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Allergy and Immunology
Biological Products
Inflammatory Bowel Diseases
Genome-Wide Association Study
Microbiota
Immune System Diseases
Immune System
Clinical Trials
Technology
Therapeutics

Keywords

  • Adaptive immunity
  • Biologics
  • IBD
  • Immunology
  • Innate immunity

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{4c5d5e3f2ad44fe9940c2ec443ec4ec8,
title = "Immunology of Inflammatory Bowel Disease and Molecular Targets for Biologics",
abstract = "Inflammatory bowel disease (IBD) is an immune-mediated disease and involves a complex interplay of host genetics and environmental influences. Recent advances in the field, including data from genome-wide association studies and microbiome analysis, have started to unravel the complex interaction between host genetics and environmental influences in the pathogenesis of IBD. A drawback of current clinical trials is inadequate or lack of immune phenotyping of patients. However, recent advances in high-throughput technologies provide an opportunity to monitor the dynamic and complex immune system, which may to lead to a more personalized treatment approach in IBD.",
keywords = "Adaptive immunity, Biologics, IBD, Immunology, Innate immunity",
author = "Maneesh Dave and Konstantinos Papadakis and Faubion, {William Alvis}",
year = "2014",
doi = "10.1016/j.gtc.2014.05.003",
language = "English (US)",
volume = "43",
pages = "405--424",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Immunology of Inflammatory Bowel Disease and Molecular Targets for Biologics

AU - Dave, Maneesh

AU - Papadakis, Konstantinos

AU - Faubion, William Alvis

PY - 2014

Y1 - 2014

N2 - Inflammatory bowel disease (IBD) is an immune-mediated disease and involves a complex interplay of host genetics and environmental influences. Recent advances in the field, including data from genome-wide association studies and microbiome analysis, have started to unravel the complex interaction between host genetics and environmental influences in the pathogenesis of IBD. A drawback of current clinical trials is inadequate or lack of immune phenotyping of patients. However, recent advances in high-throughput technologies provide an opportunity to monitor the dynamic and complex immune system, which may to lead to a more personalized treatment approach in IBD.

AB - Inflammatory bowel disease (IBD) is an immune-mediated disease and involves a complex interplay of host genetics and environmental influences. Recent advances in the field, including data from genome-wide association studies and microbiome analysis, have started to unravel the complex interaction between host genetics and environmental influences in the pathogenesis of IBD. A drawback of current clinical trials is inadequate or lack of immune phenotyping of patients. However, recent advances in high-throughput technologies provide an opportunity to monitor the dynamic and complex immune system, which may to lead to a more personalized treatment approach in IBD.

KW - Adaptive immunity

KW - Biologics

KW - IBD

KW - Immunology

KW - Innate immunity

UR - http://www.scopus.com/inward/record.url?scp=84905676302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905676302&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2014.05.003

DO - 10.1016/j.gtc.2014.05.003

M3 - Article

C2 - 25110250

AN - SCOPUS:84905676302

VL - 43

SP - 405

EP - 424

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

IS - 3

ER -